1. Home
  2. TBLA vs GPCR Comparison

TBLA vs GPCR Comparison

Compare TBLA & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$3.09

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$56.44

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
GPCR
Founded
2007
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
6.3B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
TBLA
GPCR
Price
$3.09
$56.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$5.00
$104.64
AVG Volume (30 Days)
2.1M
701.0K
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.95
N/A
Revenue Next Year
$5.62
N/A
P/E Ratio
$42.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.63
$13.24
52 Week High
$4.65
$94.90

Technical Indicators

Market Signals
Indicator
TBLA
GPCR
Relative Strength Index (RSI) 40.27 34.11
Support Level $3.03 $18.36
Resistance Level $3.56 $93.91
Average True Range (ATR) 0.17 3.39
MACD 0.02 -0.50
Stochastic Oscillator 41.73 24.35

Price Performance

Historical Comparison
TBLA
GPCR

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: